» Articles » PMID: 34566630

Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards Models and Adverse Outcome Pathways

Overview
Journal Front Pharmacol
Date 2021 Sep 27
PMID 34566630
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Nanotoxicology is an emerging field employed in the assessment of unintentional hazardous effects produced by nanoparticles (NPs) impacting human health and the environment. The nanotoxicity affects the range between induction of cellular stress and cytotoxicity. The reasons so far reported for these toxicological effects are due to their variable sizes with high surface areas, shape, charge, and physicochemical properties, which upon interaction with the biological components may influence their functioning and result in adverse outcomes (AO). Thus, understanding the risk produced by these materials now is an important safety concern for the development of nanotechnology and nanomedicine. Since the time nanotoxicology has evolved, the methods employed have been majorly relied on cell-based evaluations, while these simple methods may not predict the complexity involved in preclinical and clinical conditions concerning pharmacokinetics, organ toxicity, and toxicities evidenced through multiple cellular levels. The safety profiles of nanoscale nanomaterials and nanoformulations in the delivery of drugs and therapeutic applications are of considerable concern. In addition, the safety assessment for new nanomedicine formulas lacks regulatory standards. Though the studies are greatly needed, the end parameters used for risk assessment are not predicting the possible toxic effects produced by various nanoformulations. On the other side, due to increased restrictions on animal usage and demand for the need for high-throughput assays, there is a need for developing and exploring novel methods to evaluate NPs safety concerns. The progress made in molecular biology and the availability of several modern techniques may offer novel and innovative methods to evaluate the toxicological behavior of different NPs by using single cells, cell population, and whole organisms. This review highlights the recent novel methods developed for the evaluation of the safety impacts of NPs and attempts to solve the problems that come with risk assessment. The relevance of investigating adverse outcome pathways (AOPs) in nanotoxicology has been stressed in particular.

Citing Articles

Therapeutic Potential of Green Synthesized Polyherbal Formulated Silver Nanoparticles in Alloxan-Induced Diabetes Mellitus-An In Vivo Strategy.

Afshin N, Mushtaq N, Ahmed M, Badshah S, Wazir S, Badshah F Biol Trace Elem Res. 2025; .

PMID: 40075015 DOI: 10.1007/s12011-025-04566-5.


Recent advances in the bench-to-bedside translation of cancer nanomedicines.

Liu Y, Zhang Y, Li H, Hu T Acta Pharm Sin B. 2025; 15(1):97-122.

PMID: 40041906 PMC: 11873642. DOI: 10.1016/j.apsb.2024.12.007.


Susceptibility of Human Spermatozoa to Titanium Dioxide Nanoparticles: Evaluation of DNA Damage and Biomarkers.

Scalisi E, Pecoraro R, Scalisi A, Dragotto J, Bracchitta G, Zimbone M Life (Basel). 2024; 14(11).

PMID: 39598253 PMC: 11595473. DOI: 10.3390/life14111455.


In Vivo Efficacy of a Nanoconjugated Glycopeptide Antibiotic in Silkworm Larvae Infected by .

Montali A, Berini F, Gamberoni F, Armenia I, Saviane A, Cappellozza S Insects. 2024; 15(11).

PMID: 39590485 PMC: 11595181. DOI: 10.3390/insects15110886.


Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines.

Havelikar U, Ghorpade K, Kumar A, Patel A, Singh M, Banjare N Discov Nano. 2024; 19(1):165.

PMID: 39365367 PMC: 11452581. DOI: 10.1186/s11671-024-04118-1.


References
1.
Li Y, Ju D . The Role of Autophagy in Nanoparticles-Induced Toxicity and Its Related Cellular and Molecular Mechanisms. Adv Exp Med Biol. 2018; 1048:71-84. DOI: 10.1007/978-3-319-72041-8_5. View

2.
Song J, Xu C, Huang S, Lei W, Ruan Y, Lu H . Ultrasmall Nanopipette: Toward Continuous Monitoring of Redox Metabolism at Subcellular Level. Angew Chem Int Ed Engl. 2018; 57(40):13226-13230. DOI: 10.1002/anie.201808537. View

3.
Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M . Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol. 2011; 6(5):321-8. DOI: 10.1038/nnano.2011.41. View

4.
Dusinska M, Tulinska J, El Yamani N, Kuricova M, Liskova A, Rollerova E . Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?. Food Chem Toxicol. 2017; 109(Pt 1):797-811. DOI: 10.1016/j.fct.2017.08.030. View

5.
Al Faraj A, Cieslar K, Lacroix G, Gaillard S, Canet-Soulas E, Cremillieux Y . In vivo imaging of carbon nanotube biodistribution using magnetic resonance imaging. Nano Lett. 2009; 9(3):1023-7. DOI: 10.1021/nl8032608. View